Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic Region
Clinical trial NCT00197028 · COMPLETED
Trial details
- NCT number
- NCT00197028
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-23
- Primary completion
- 2007-12-27
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.